These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 15454345)
1. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys. Wakasa Y; Fujiwara A; Umeuchi H; Endoh T; Okano K; Tanaka T; Nagase H Life Sci; 2004 Oct; 75(24):2947-57. PubMed ID: 15454345 [TBL] [Abstract][Full Text] [Related]
2. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366 [TBL] [Abstract][Full Text] [Related]
3. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice. Sakakihara M; Imamachi N; Saito Y Reg Anesth Pain Med; 2016; 41(1):69-74. PubMed ID: 26587674 [TBL] [Abstract][Full Text] [Related]
4. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. Ko MC; Husbands SM J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704 [TBL] [Abstract][Full Text] [Related]
5. [Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis]. Nakao K; Ikeda K; Kurokawa T; Togashi Y; Umeuchi H; Honda T; Okano K; Mochizuki H Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):75-83. PubMed ID: 18516986 [TBL] [Abstract][Full Text] [Related]
6. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions. Suzuki T; Izumimoto N; Takezawa Y; Fujimura M; Togashi Y; Nagase H; Tanaka T; Endoh T Brain Res; 2004 Jan; 995(2):167-75. PubMed ID: 14672806 [TBL] [Abstract][Full Text] [Related]
7. The role of central mu opioid receptors in opioid-induced itch in primates. Ko MC; Song MS; Edwards T; Lee H; Naughton NN J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556 [TBL] [Abstract][Full Text] [Related]
10. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice. Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039 [TBL] [Abstract][Full Text] [Related]
11. Involvement of peripheral mu opioid receptors in scratching behavior in mice. Yamamoto A; Sugimoto Y Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827 [TBL] [Abstract][Full Text] [Related]
12. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice. Takasaki I; Suzuki T; Sasaki A; Nakao K; Hirakata M; Okano K; Tanaka T; Nagase H; Shiraki K; Nojima H; Kuraishi Y J Pharmacol Exp Ther; 2004 Apr; 309(1):36-41. PubMed ID: 14711930 [TBL] [Abstract][Full Text] [Related]
13. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Kamei J; Nagase H Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876 [TBL] [Abstract][Full Text] [Related]
14. A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice. Tsuji M; Takeda H; Matsumiya T; Nagase H; Yamazaki M; Narita M; Suzuki T Life Sci; 2000; 66(25):PL353-8. PubMed ID: 10894094 [TBL] [Abstract][Full Text] [Related]
15. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist. Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186 [TBL] [Abstract][Full Text] [Related]
16. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Umeuchi H; Togashi Y; Honda T; Nakao K; Okano K; Tanaka T; Nagase H Eur J Pharmacol; 2003 Sep; 477(1):29-35. PubMed ID: 14512095 [TBL] [Abstract][Full Text] [Related]
17. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats. Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822 [TBL] [Abstract][Full Text] [Related]
18. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys. Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348 [TBL] [Abstract][Full Text] [Related]
19. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats. Mori T; Nomura M; Nagase H; Narita M; Suzuki T Psychopharmacology (Berl); 2002 Apr; 161(1):17-22. PubMed ID: 11967626 [TBL] [Abstract][Full Text] [Related]
20. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]